This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Multidimensional outlook on the pathophysiology of cervical cancer invasion and metastasis
Molecular and Cellular Biochemistry Open Access 11 March 2023
-
KLK10 exon 3 unmethylated PCR product concentration: a new potential early diagnostic marker in ovarian cancer? - A pilot study
Journal of Ovarian Research Open Access 24 April 2018
-
The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer
British Journal of Cancer Open Access 14 April 2009
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Roman-Gomez J, Castillejo JA, Jimenez A, Gonzalez MG, Moreno F, Rodriguez MC et al. 5′ CpG island hypermethylation is associated with transcriptional silencing of the p21CIP1/WAF1/SDI1gene and confers poor prognosis in acute lymphoblastic leukemia. Blood 2002; 99: 2291–2296.
Goyal J, Smith KM, Cowan JM, Wazer DE, Lee W, Band V . The role of NES1 serine protease as a novel tumor suppressor. Cancer Res 1998; 58: 4782–4786.
Li B, Goyal J, Dhar S, Goberdhan D, Evron E, Sukumar S et al. CpG methylation as a basis for breast tumor-specific loss of NES1/kallikrein 10 expression. Cancer Res 2001; 61: 8014–8021.
Takeuchi S, Bartram CR, Wada M, Reiter A, Hatta Y, Seriu T et al. Allelotype analysis of childhood acute lymphoblastic leukemia. Cancer Res 1995; 55: 5377–5382.
Malone CS, Miner MD, Doerr JR, Jackson JP, Jacobsen SE, Wall R et al. CmC(A/T)GG DNA methylation in mature B cell lymphoma gene silencing. Proc Natl Acad Sci USA 2001; 98: 10404–10409.
Nguyen C, Liang G, Nguyen TT, Tsao-Wei D, Groshen S, Lubbert M et al. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells. J Natl Cancer Inst 2001; 93: 1465–1472.
Dhar S, Bhargava R, Yunes M, Li B, Goyal J, Naber SP et al. Analysis of normal epithelial cell specific-1 (NES1)/kallikrein 10 mRNA expression by in situ hybridization, a novel marker for breast cancer. Clin Cancer Res 2001; 7: 3393–3398.
Yousef GM, Diamandis EP . Expanded human tissue kallikrein family – a novel panel of cancer biomarkers. Tumor Biol 2002; 23: 185–192.
Acknowledgements
This work is supported by grants from Fondo de Investigaciones Sanitarias (FIS, Spain) 01/0662, 01/0013-01, 01/F018, 02/1299; Navarra Goverment (31/2002); RETIC C03/10 and funds from Cajamar-Fundacion Hospital Carlos Haya (Malaga, Spain).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Roman-Gomez, J., Jimenez-Velasco, A., Agirre, X. et al. The normal epithelial cell-specific 1 (NES1) gene, a candidate tumor suppressor gene on chromosome 19q13.3–4, is downregulated by hypermethylation in acute lymphoblastic leukemia. Leukemia 18, 362–365 (2004). https://doi.org/10.1038/sj.leu.2403223
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403223
This article is cited by
-
Multidimensional outlook on the pathophysiology of cervical cancer invasion and metastasis
Molecular and Cellular Biochemistry (2023)
-
KLK10 exon 3 unmethylated PCR product concentration: a new potential early diagnostic marker in ovarian cancer? - A pilot study
Journal of Ovarian Research (2018)
-
The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer
British Journal of Cancer (2009)
-
Emerging roles of proteases in tumour suppression
Nature Reviews Cancer (2007)
-
ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia
Oncogene (2006)